US Stock MarketDetailed Quotes

NEO NeoGenomics

Watchlist
  • 14.420
  • +0.510+3.67%
Close Feb 14 16:00 ET
  • 14.570
  • +0.150+1.04%
Post 19:58 ET
1.85BMarket Cap-23.64P/E (TTM)

NeoGenomics Key Stats

NeoGenomics Q4 2024 Estimates Date

Currency:USDFeb 18, 2025

Estimate YoY
Revenue
173.40M
+11.47%
EPS
-0.13
-20.84%
Buy

Feb 16, 2025

NeoGenomics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 10 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 172.625M--
Feb 18, 20252024/Q4-- / 173.399M--
Nov 5, 20242024/Q3167.824M / 167.028M--
Jul 29, 20242024/Q2164.502M / 162.002M--
Apr 30, 20242024/Q1156.240M / 149.700M--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 172.625M--
Feb 18, 20252024/Q4-- / 173.399M--
Nov 5, 20242024/Q3167.824M / 167.028M--
Jul 29, 20242024/Q2164.502M / 162.002M--
Apr 30, 20242024/Q1156.240M / 149.700M--

Unlock Free Earnings Estimates

NeoGenomics Earnings Reports

Read more

Trending Stocks

Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

Unlock Now